Viyash Scientific updates on BioForLife Italia acquisition approval and timeline
Viyash Scientific Ltd · Pharmaceuticals & Biotechnology
What the filing says
- Received Italian FDI/Golden Power regulatory approval for BioForLife Italia acquisition
- Acquisition by Alivira Animal Health, a wholly owned subsidiary, to complete within two months
- All other material terms and conditions from previous disclosures remain unchanged
Why it's rated notable: The filing reports receipt of Italian Golden Power approval and a revised completion window of two months, but states no transaction value and says closing formalities and conditions remain, so the level is medium.
Original filing
Update On Proposed Acquisition Of Bioforlife Italia S.R.L
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Sancode Technologies' subsidiary agrees to acquire Cirtek Electronics Corporation
- Aeroflex Enterprises completes acquisition of 51.01% stake in Stilonn Valves
- Capital Infra Trust completes acquisition of 100% equity in six Gawar highway SPVs
- Shrem InvIT completes acquisition of 100% equity in Chilakaluripet Bypass Pvt Ltd
- Newgen Software Technologies approves quarter and half-year results and amalgamation scheme
- Raajmarg Infra Investment Trust to potentially acquire 10 NHAI road assets in FY 2026-27
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.